Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.
about
Augmentation with antidepressants in schizophrenia treatment: benefit or riskReciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agentsAntidepressant-like activity of amisulpride in two animal models of depressionAnti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trialPostpsychotic depression in schizophrenia patients.The relationships between depression and remission in first-episode psychosisSuicidal behavior in the older patient with schizophrenia.Suicide risk in schizophrenia: learning from the past to change the future.The negative symptoms of schizophrenia: a cognitive perspective.Symptom domains of schizophrenia: the role of atypical antipsychotic agents.Emotional processing in schizophrenia.rTMS strategies for the study and treatment of schizophrenia: a review.Personality trait correlates of color preference in schizophreniaInterpersonal distances, coping strategies and psychopathology in patients with depression and schizophrenia.The patient's diagnosis: explanatory models of mental illness.Schizophrenia and the life cycle.Depression in schizophrenia: a descriptive study.Schizophrenia. A cognitive model and its implications for psychological intervention.Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia.Efficacy of milnacipran for depressive symptoms in schizophrenia spectrum disorders.Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial.Opportunities and challenges presented by the new generation antipsychotics.Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients.Do People With Psychosis Have Specific Difficulties Regulating Emotions?Negative, not positive symptoms predict the early therapeutic alliance in cognitive behavioral therapy for psychosis.Higher levels of depression are associated with reduced global bias in visual processing.Is smoking linked to positive symptoms in acutely ill psychiatric patients?[Developmental process of DGPPN quality indicators].A community-based clinic survey of antidepressant use in persons with schizophrenia.Reliability and validity of the Chinese version of the Calgary Depression Scale for Schizophrenia.Yoga therapy as an add-on treatment in the management of patients with schizophrenia--a randomized controlled trial.Clinical issues related to depression in schizophrenia: an international survey of psychiatrists.The importance of treatment acceptability to patients
P2860
Q26851841-04E8B83B-DBD8-433E-9B90-B46832E555B7Q28140526-D1EF944E-F8E0-4FA1-A69E-8FA362529D11Q28141401-D25724CA-EF79-4ED5-A7CA-AE3EAC223A5BQ34007868-0E685233-1718-400F-BB92-189253043091Q34749196-206F9035-44AA-4360-B258-11070C1A178EQ35129876-F86C6BB7-CC87-4CB5-9A65-0F6BFDF4C702Q35414138-37180187-7CDA-4D6C-A9E1-B660B66883ECQ35738863-9D557CF8-FAC2-4F67-834F-22CDB9A7F8C0Q36169573-22D90DDA-2D95-45D6-8EF6-3284EC862910Q36626242-62BBFA8C-E8D0-4323-8BB1-DC5A3EF74EABQ36758406-466DCB4B-A7EC-42A0-824A-B52D75214E22Q37074280-AFFA7970-8639-4737-B41C-C6748E731053Q37074574-6351F4FB-2EBA-40CA-8B64-AFA15D8B231FQ37322003-C28B2E64-3BCF-4812-A4B3-9C265F12AC82Q39531931-8FD33B8B-236D-4EF3-8E56-4831990AD06CQ40452041-8FF2B96A-FD2E-4922-AB36-95F9F4EFFDC2Q41138453-E017954B-F943-471C-837E-1CF20348BC47Q41231694-F7C9FF87-8F6D-48D7-8E53-45D2D34BD111Q44518148-49599F57-5B38-4727-B04D-7C2BC41AB2D9Q44792446-220D053B-CE65-422F-BB06-6FA8A234F86DQ46516264-AC96BF25-0195-4325-ADB9-62C367F9EB21Q47596300-19E05218-1A08-412C-975A-1F27CE8C0824Q47768018-F1D18AC6-7FDC-45DA-9E2E-FB0C3F29A63EQ47809220-9FCBAF5F-C154-4B04-B9F0-D4EC56E4672AQ48401934-30EBD796-F521-4AC4-98CB-05B6BA048250Q48421955-671FF433-97BE-4427-9CAD-7FF561AECF23Q50610232-2583CDBB-CF12-482B-A315-B421D978683BQ50754002-005A2CFE-C2F5-4FD5-BACC-9D93ADEE92A7Q50878501-7A2DEA8B-6037-4E10-B307-52F59C67A460Q51869330-36C350C2-71AF-48F3-8961-80DDDF5CECF9Q51901128-93632BD7-FE7A-4001-90E6-9348EDAC19EEQ53315999-A49EE008-C69E-4D38-8894-BC01825A7EE8Q57739162-C146C66E-2DAC-451D-AD8B-1806F45E54A0
P2860
Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.
@en
Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.
@nl
type
label
Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.
@en
Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.
@nl
prefLabel
Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.
@en
Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.
@nl
P356
P1476
Diagnosis of secondary depression in schizophrenia: implications for DSM-IV.
@en
P2093
P356
10.1093/SCHBUL/17.1.75
P407
P577
1991-01-01T00:00:00Z